188 related articles for article (PubMed ID: 34980013)
1. Factors associated with response to compression-based physical therapy for secondary lower limb lymphedema after gynecologic cancer treatment: a multicenter retrospective study.
Yoshihara M; Kitamura K; Tsuru S; Shimono R; Sakuda H; Mayama M; Tano S; Uno K; Ukai MO; Kishigami Y; Oguchi H; Hirota A
BMC Cancer; 2022 Jan; 22(1):25. PubMed ID: 34980013
[TBL] [Abstract][Full Text] [Related]
2. Incidence and risk factors for lower limb lymphedema after gynecologic cancer surgery with initiation of periodic complex decongestive physiotherapy.
Deura I; Shimada M; Hirashita K; Sugimura M; Sato S; Sato S; Oishi T; Itamochi H; Harada T; Kigawa J
Int J Clin Oncol; 2015 Jun; 20(3):556-60. PubMed ID: 24993674
[TBL] [Abstract][Full Text] [Related]
3. Risk factors and a prediction model for lower limb lymphedema following lymphadenectomy in gynecologic cancer: a hospital-based retrospective cohort study.
Kuroda K; Yamamoto Y; Yanagisawa M; Kawata A; Akiba N; Suzuki K; Naritaka K
BMC Womens Health; 2017 Jul; 17(1):50. PubMed ID: 28743274
[TBL] [Abstract][Full Text] [Related]
4. Does initial routine use of a compression garment reduce the risk of lower limb lymphedema after gynecological cancer treatment? A randomized pilot study in an Asian institution and review of the literature.
Hnin YK; Ong LX; Tsai CC; Ong SS; Yee SG; Choo BA; Low JJ
Lymphology; 2018; 51(4):174-183. PubMed ID: 31119907
[TBL] [Abstract][Full Text] [Related]
5. Evidence-based practice in the management of lower limb lymphedema after gynecological cancer.
Iwersen LF; Sperandio FF; Toriy AM; Palú M; Medeiros da Luz C
Physiother Theory Pract; 2017 Jan; 33(1):1-8. PubMed ID: 27918865
[TBL] [Abstract][Full Text] [Related]
6. Frequency and risk factors of lower limb lymphedema following lymphadenectomy in patients with gynecological malignancies.
Graf N; Rufibach K; Schmidt AM; Fehr M; Fink D; Baege AC
Eur J Gynaecol Oncol; 2013; 34(1):23-7. PubMed ID: 23589994
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of complex decongestive physiotherapy (CDP) and predictive factors of response to CDP in lower limb lymphedema (LLL) after pelvic cancer treatment.
Liao SF; Li SH; Huang HY
Gynecol Oncol; 2012 Jun; 125(3):712-5. PubMed ID: 22426250
[TBL] [Abstract][Full Text] [Related]
8. Lower limb lymphedema and neurological complications after lymphadenectomy for gynecological cancer.
Biglia N; Librino A; Ottino MC; Panuccio E; Daniele A; Chahin A
Int J Gynecol Cancer; 2015 Mar; 25(3):521-5. PubMed ID: 25621410
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for late-onset lower limb lymphedema after gynecological cancer treatment: A multi-institutional retrospective study.
Yoshihara M; Shimono R; Tsuru S; Kitamura K; Sakuda H; Oguchi H; Hirota A
Eur J Surg Oncol; 2020 Jul; 46(7):1334-1338. PubMed ID: 32146054
[TBL] [Abstract][Full Text] [Related]
10. Complications of lymphadenectomy for gynecologic cancer.
Achouri A; Huchon C; Bats AS; Bensaid C; Nos C; Lécuru F
Eur J Surg Oncol; 2013 Jan; 39(1):81-6. PubMed ID: 23117018
[TBL] [Abstract][Full Text] [Related]
11. Impact of lower limb lymphedema on quality of life in gynecologic cancer survivors after pelvic lymph node dissection.
Kim SI; Lim MC; Lee JS; Lee Y; Park K; Joo J; Seo SS; Kang S; Chung SH; Park SY
Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():31-6. PubMed ID: 26142914
[TBL] [Abstract][Full Text] [Related]
12. Current Status and Progress in the Treatment of Lower Limb Lymphedema After Treatment of Gynecological Oncology.
Zhang H; Kong W; Han C; Liu T; Li J; Song D
Lymphat Res Biol; 2022 Jun; 20(3):308-314. PubMed ID: 34698556
[No Abstract] [Full Text] [Related]
13. Incidence of lymphedema in the lower limbs and lymphocyst formation within one year of surgery for endometrial cancer: A prospective longitudinal multicenter study.
Wedin M; Stålberg K; Marcickiewicz J; Ahlner E; Åkesson Å; Lindahl G; Kjølhede P;
Gynecol Oncol; 2020 Oct; 159(1):201-208. PubMed ID: 32763108
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of undiagnosed postoperative lower limb lymphedema among gynecological oncology patients.
Wong M; Eaton PK; Zanichelli C; Moore C; Hegarty C; MacDonald N
Eur J Surg Oncol; 2022 May; 48(5):1167-1172. PubMed ID: 34980543
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Decongestive Therapy as a Treatment for Secondary Lymphedema of the Lower Extremity and Quality of Life of Women After Gynecological Cancer Surgery.
Kendrová L; Mikuľáková W; Urbanová K; Andraščíková Š; Žultáková S; Takáč P; Peresta Y
Med Sci Monit; 2020 Jun; 26():e924071. PubMed ID: 32555125
[TBL] [Abstract][Full Text] [Related]
16. Use of lymphoscintigraphy to differentiate primary versus secondary lower extremity lymphedema after surgical lymphadenectomy: a retrospective analysis.
Roman MM; Barbieux R; Nogaret JM; Bourgeois P
World J Surg Oncol; 2018 Apr; 16(1):75. PubMed ID: 29631609
[TBL] [Abstract][Full Text] [Related]
17. Retrospective study on the trajectories of lower limb volume after outpatient-based complex decongestive therapy in post-operative gynecological cancer patients with lymphedema.
Masui A; Harada T; Noda Y; Soeda R; Kida H; Tsuji T
Support Care Cancer; 2023 May; 31(6):318. PubMed ID: 37148389
[TBL] [Abstract][Full Text] [Related]
18. The effect of lumbar sympathetic ganglion block on gynecologic cancer-related lymphedema.
Woo JH; Park HS; Kim SC; Kim YH
Pain Physician; 2013; 16(4):345-52. PubMed ID: 23877450
[TBL] [Abstract][Full Text] [Related]
19. Systematic review of quality of life and patient reported outcomes in patients with oncologic related lower extremity lymphedema.
Cemal Y; Jewell S; Albornoz CR; Pusic A; Mehrara BJ
Lymphat Res Biol; 2013 Mar; 11(1):14-9. PubMed ID: 23531180
[TBL] [Abstract][Full Text] [Related]
20. Lumbar Sympathetic Ganglion Block for Cancer-Associated Secondary Lower Limb Lymphedema: A Retrospective Study.
Huang H; Lin J; Dai Z; Zeng M; Li S; Zheng H
Pain Physician; 2022 Nov; 25(8):E1269-E1277. PubMed ID: 36375200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
